Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Long-Term Debt Repayments (2020 - 2025)

Historic Long-Term Debt Repayments for Aytu Biopharma (AYTU) over the last 6 years, with Q4 2025 value amounting to $465000.0.

  • Aytu Biopharma's Long-Term Debt Repayments changed 0.0% to $465000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $1.9 million, marking a year-over-year decrease of 8881.73%. This contributed to the annual value of $1.9 million for FY2025, which is 8818.85% down from last year.
  • Latest data reveals that Aytu Biopharma reported Long-Term Debt Repayments of $465000.0 as of Q4 2025, which was down 0.0% from $464000.0 recorded in Q3 2025.
  • In the past 5 years, Aytu Biopharma's Long-Term Debt Repayments ranged from a high of $89.6 million in Q4 2021 and a low of -$73.6 million during Q1 2022
  • For the 5-year period, Aytu Biopharma's Long-Term Debt Repayments averaged around $1.8 million, with its median value being $59000.0 (2021).
  • Its Long-Term Debt Repayments has fluctuated over the past 5 years, first crashed by 16356000.0% in 2022, then surged by 6795217.39% in 2024.
  • Over the past 5 years, Aytu Biopharma's Long-Term Debt Repayments (Quarter) stood at $89.6 million in 2021, then plummeted by 100.03% to -$26000.0 in 2022, then skyrocketed by 188.46% to $23000.0 in 2023, then surged by 1921.74% to $465000.0 in 2024, then changed by 0.0% to $465000.0 in 2025.
  • Its Long-Term Debt Repayments was $465000.0 in Q4 2025, compared to $464000.0 in Q3 2025 and $464000.0 in Q2 2025.